Tag: Cancer: Breast
Doctors’ Personal Experience of Breast Cancer May Impact Care
Physicians with social network member with poor prognosis more likely to recommend screening
FDA Approves Biosimilar Ogivri for Breast, Stomach Cancers
Ogivri is approved to treat HER2+ breast and gastric or gastroesophageal junction adenocarcinoma cancers
Mortality Up for Some Cancers in Urban-Dwelling Native Americans
Urban American Indians and Alaskan Natives with cancer have significantly higher comorbidity burden
RSNA: BMI Linked to Detection of Larger Breast Tumors
BMI linked to detection of tumor larger than 2 cm among screen-detected and interval cancers
NAFLD Linked to Increased Cancer Incidence Rate
NAFLD strongly tied to development of hepatocellular carcinoma, CRC in males, breast cancer in females
ER- Breast CA Risk Up for African-Americans With T2DM
ER- type accounts for increased breast cancer risk in African-American women; highest risk in nonobese
Breast Cancer Recurrences Steady After Therapy Cessation
Women with ER-positive BC who stop therapy after 5 years have steady recurrence rate up to 20 years
Incidence of Early-Stage Breast CA, CRC Up With ACA Adoption
No change in incidence of locally advanced or metastatic-stage cancer after ACA adoption
PARP Inhibitors Promising Beyond BRCA1/2 Altered Tumors
Talazoparib caused regression in 5 patient-derived xenografts, 4 without germline BRCA1/2 mutations
Elastography and Color Doppler Improve Breast Ultrasound
Together, the technologies increase predictive value of screening while decreasing unnecessary biopsies
